Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturationAlessandra Aldinucci, Gianni Gerlini, Silvia Fossati, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 12, 2004
Stereoselective synthesis and preliminary evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonistGabriele Costantino, Maura Marinozzi, Emidio Camaioni, et al.
Neuropharmacology|May 17, 2002
The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal deathFlavio Moroni, Sabina Attucci, Andrea Cozzi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 25, 2012
Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermiaMirko Muzzi, Francesco Blasi, Alessio Masi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2003
Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemiaAlberto Chiarugi, Elena Meli, Maura Calvani, et al.
Journal of Neurochemistry|April 29, 2020
Differential mechanisms of tolerance induced by NMDA and 3,5-dihydroxyphenylglycine (DHPG) preconditioningElisabetta Gerace, Elisa Zianni, Elisa Landucci, et al.
Plos One|September 30, 2014
Arrays of microLEDs and astrocytes: biological amplifiers to optogenetically modulate neuronal networks reducing light requirementRolando Berlinguer-Palmini, Roberto Narducci, Kamyar Merhan, et al.
European Addiction Research|February 3, 2018
Methadone Dose Adjustments, Plasma R-Methadone Levels and Therapeutic Outcome of Heroin Users: A Randomized Clinical TrialGuido Mannaioni, Cecilia Lanzi, Michela Lotti, et al.
British Journal of Pharmacology|February 19, 2017
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseasesNathan A Berger, Valerie C Besson, A Hamid Boulares, et al.
Pageof 7